Related Experiment Video
Updated: Jul 4, 2026
03:55
Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer
Published on: June 9, 2023
470
ENDOCAN TUTHYREF network consensus recommendations: Refractory follicular-derived thyroid cancer
Christine Do Cao1, Yann Godbert2, Stéphane Bardet3
1Department of Endocrinology, CHRU de Lille-Hôpital Claude Huriez, Lille, France.
Annales D'Endocrinologie
|May 9, 2025
Summary
Management of radioactive-iodine-refractory differentiated thyroid cancer (RAIR DTC) requires personalized strategies. Recommendations focus on molecular testing, tailored treatments, and proactive patient monitoring for optimal outcomes in this rare cancer.
Area of Science:
- Oncology
- Endocrinology
Background:
- Radioactive-iodine-refractory differentiated thyroid cancer (RAIR DTC) affects 3-5% of follicular-derived DTCs, with a median survival of 9.5 years.
- Long-term patient and caregiver support is crucial due to the chronic nature of RAIR DTC.
Framework:
- The French ENDOCAN TUTHYREF network provides updated algorithms for RAIR DTC management.
- Recommendations refine the definition of RAIR DTC using prognostic factors.
- Treatment decisions should consider tumor burden and progression rate.
Implementation:
- Prioritize local treatments for non-progressive or slowly progressive disease.
- Perform early molecular testing to identify actionable oncogenes (BRAF, RET/NTRK/ALK).
- Utilize tyrosine multikinase inhibitors (e.g., sorafenib, lenvatinib) for symptomatic or progressive RAIR DTC.
Implications:
- Personalized treatment strategies are essential for RAIR DTC.
- Multidisciplinary care and proactive therapeutic education are key.
- Careful patient monitoring for side effects (fatigue, cardiovascular, skin) and dose adjustment is necessary.
Related Concept Videos
02:56Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
02:56Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
01:23The Thyroid Gland
The thyroid gland is a small, butterfly-shaped gland located in the neck and covers the anterior surface of the trachea. The gland has two lateral lobes connected by a thin tissue mass called the isthmus. Internally, each lobe comprises many small spherical structures known as thyroid follicles, surrounded by a network of blood vessels.
The follicles have a central cavity lined by simple cuboidal to squamous epithelial cells called follicular cells. These cells produce the glycoprotein...
The follicles have a central cavity lined by simple cuboidal to squamous epithelial cells called follicular cells. These cells produce the glycoprotein...
01:20Synthesis and Regulation of Thyroid Hormones
Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The iodine is then...
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The iodine is then...
01:27Hyperthyroidism II: Pathophysiology
Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...